How to buy amivantamab in the country

Amivantamab (amivantamab) is an innovative targeted drug developed by Janssen, a subsidiary of Johnson & Johnson. It targets epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET) at the same time, opening up a new direction in the treatment of non-small cell lung cancer. The drug was first approved in the United States and Europe for patients with EGFR exon 20 insertion mutations, and has since been gradually promoted to more countries and regions. In recent years, evantumumab has been officially launched in China, but due to the short time to market, it is still in the stage of gradual improvement of the supply chain and clinical application.

For domestic patients, there are several main ways to purchase evantumumab. The first is through the departments of some large tertiary hospitals. Doctors will decide whether to use the drug based on the patient's genetic test results and condition assessment, and apply for purchase through qualified pharmacy channels. However, it should be noted that evantumumab has not yet been included in the national medical insurance catalog, so the cost of the drug must be borne by the patient, which is a large financial expenditure for some families. Secondly, some patients will obtain drugs through cross-border purchases, such as in Hong Kong and Macao, Japan and South Korea, or European and American countries. The prices may be slightly different, but they need to ensure that the sources are regular to avoid purchasing substandard drugs. In addition, there are some certified cross-border medical platforms that can help patients apply for imported drugs through legal channels, but they often need to wait for the approval process and a long delivery cycle.

Currently, there is no generic version of evantuzumab, and only the original drug is available on the market, so the price is relatively high. According to international market conditions, the price of one dose of evantumumab is usually around tens of thousands of yuan, and the specific cost will also be affected by dosage, course of treatment, and exchange rate fluctuations. When domestic patients consider purchasing drugs, in addition to the drug itself, they should also pay attention to the overall economic affordability of long-term treatment.

Reference materials:https://www.rybrevant.com/